Published on 18 Apr 2024 on Seeking Alpha
PacBio stock cut to Neutral at Goldman Sachs (NASDAQ:PACB)
Goldman Sachs downgrades PacBio (PACB) stock to Neutral from Buy due to the gene sequencing...
NASDAQ.PACB price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free